Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.

Zhao LY, Zhang J, Guo B, Yang J, Han J, Zhao XG, Wang XF, Liu LY, Li ZF, Song TS, Huang C.

Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;Suppl 59:OL1876-81.

PMID:
24199952
2.

CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.

Chen TJ, Gao F, Yang T, Thakur A, Ren H, Li Y, Zhang S, Wang T, Chen MW.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):108-13. doi: 10.1016/j.bbrc.2013.06.048. Epub 2013 Jun 24.

PMID:
23806693
3.

S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.

Wu R, Duan L, Ye L, Wang H, Yang X, Zhang Y, Chen X, Zhang Y, Weng Y, Luo J, Tang M, Shi Q, He T, Zhou L.

Int J Oncol. 2013 Mar;42(3):1001-10. doi: 10.3892/ijo.2013.1796. Epub 2013 Jan 23.

PMID:
23354417
4.
5.

Melittin induces PTCH1 expression by down-regulating MeCP2 in human hepatocellular carcinoma SMMC-7721 cells.

Wu X, Zhao B, Cheng Y, Yang Y, Huang C, Meng X, Wu B, Zhang L, Lv X, Li J.

Toxicol Appl Pharmacol. 2015 Oct 1;288(1):74-83. doi: 10.1016/j.taap.2015.07.010. Epub 2015 Jul 17.

PMID:
26189965
6.
7.

The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.

Chiu CY, Kuo KK, Kuo TL, Lee KT, Cheng KH.

Mol Cancer Res. 2012 Mar;10(3):415-27. doi: 10.1158/1541-7786.MCR-11-0293. Epub 2012 Jan 12.

8.

Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.

Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ.

Mol Pharmacol. 2013 May;83(5):1109-19. doi: 10.1124/mol.112.083634. Epub 2013 Mar 11.

9.

Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.

Wang H, Ye Y, Chui JH, Zhu GY, Li YW, Fong DW, Yu ZL.

Oncol Rep. 2010 Sep;24(3):647-51.

PMID:
20664969
10.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-20.e1-15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
12.

KITENIN is associated with activation of AP-1 target genes via MAPK cascades signaling in human hepatocellular carcinoma progression.

Cho SB, Park YL, Park SJ, Park SY, Lee WS, Park CH, Choi SK, Heo YH, Koh YS, Cho CK, Chung IJ, Kim KK, Kim S, Joo YE.

Oncol Res. 2011;19(3-4):115-23.

PMID:
21473287
13.

Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells.

Yan F, Wang M, Li J, Cheng H, Su J, Wang X, Wu H, Xia L, Li X, Chang HC, Li Q.

Environ Toxicol Pharmacol. 2012 Mar;33(2):181-90. doi: 10.1016/j.etap.2011.12.006. Epub 2011 Dec 10.

PMID:
22222560
14.

Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.

Cho SB, Park YL, Song YA, Kim KY, Lee GH, Cho DH, Myung DS, Park KJ, Lee WS, Chung IJ, Choi SK, Kim KK, Joo YE.

Oncol Rep. 2011 Dec;26(6):1581-6. doi: 10.3892/or.2011.1435. Epub 2011 Aug 24.

PMID:
21874262
15.

Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.

Wiesenauer CA, Yip-Schneider MT, Wang Y, Schmidt CM.

J Am Coll Surg. 2004 Mar;198(3):410-21.

PMID:
14992744
17.

MK-2206 induces cell cycle arrest and apoptosis in HepG2 cells and sensitizes TRAIL-mediated cell death.

Jiao P, Zhou YS, Yang JX, Zhao YL, Liu QQ, Yuan C, Wang FZ.

Mol Cell Biochem. 2013 Oct;382(1-2):217-24.

PMID:
23797319
18.

Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.

Li X, Lv Y, Yuan A, Yi S, Ma Y, Li Z.

Oncol Rep. 2010 Aug;24(2):441-8.

PMID:
20596631
19.

Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion.

Guo K, Liu Y, Zhou H, Dai Z, Zhang J, Sun R, Chen J, Sun Q, Lu W, Kang X, Chen P.

Cancer Sci. 2008 Mar;99(3):486-96. doi: 10.1111/j.1349-7006.2007.00702.x. Epub 2007 Dec 27.

20.

Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.

Gao Y, Lin LP, Zhu CH, Chen Y, Hou YT, Ding J.

Cancer Biol Ther. 2006 Aug;5(8):978-85. Epub 2006 Aug 3.

PMID:
16855382
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk